文献速递免疫规划

针对侵袭性细菌疫苗的体内功能性免疫保护相关性指标

In vivo functional immunoprotection correlates for vaccines against invasive bacteria.
PubMed 文献 · Vaccine · 2024-01-16

本文基于小鼠脓毒症感染模型,描述了一种新的疫苗评价系统,该系统由三个相关指标或检测组成:病原体从血流清除、病原体在肝脏截留、以及库普弗细胞与肝窦内皮细胞对病原体的捕获。这些读数与13价肺炎球菌多糖结合疫苗(PCV13)对肺炎链球菌致死感染的血型特异性免疫保护水平一致相关,并用肺炎克雷伯菌和大肠杆菌全细胞疫苗验证了其可靠性和敏感性。

要点

  • 疫苗诱导的血液病原体清除主要发生在肝脏。
  • 新评价系统包括血流清除、肝脏截留和KC/LSEC捕获三个指标。
  • 该系统可填补传统体外方法与免疫动物生存之间疫苗评价的技术空白。

核心结论

  • 基于肝脏清除血液病原体的发现,本文描述的新疫苗评价系统可定量表征有效疫苗将毒力细菌从血液循环转移至肝脏库普弗细胞和肝窦内皮细胞的关键特征。
  • 该系统的读数与PCV13对肺炎链球菌致死感染的血型特异性免疫保护水平一致相关,并在肺炎克雷伯菌和大肠杆菌全细胞疫苗中得到验证。
  • 该系统可能作为有效读数用于临床前阶段评估候选疫苗的免疫保护潜力。

研究设计与样本

  • 研究基于小鼠脓毒症感染模型,建立由三个相关指标或检测组成的疫苗评价系统。
  • 使用13价肺炎球菌多糖结合疫苗(PCV13)针对肺炎链球菌致死感染进行评价。
  • 使用肺炎克雷伯菌和大肠杆菌全细胞疫苗验证该系统的可靠性和敏感性。

主要发现

  • 新评价系统由病原体从血流清除、病原体在肝脏截留、以及病原体被库普弗细胞与肝窦内皮细胞捕获三个读数组成。
  • 这些读数与PCV13对肺炎链球菌致死感染的血型特异性免疫保护水平一致相关。
  • 该系统的可靠性和敏感性在肺炎克雷伯菌和大肠杆菌全细胞疫苗中得到验证。

临床怎么用

  • 作者认为该系统可能作为有效读数用于临床前阶段评估候选疫苗的免疫保护潜力,填补传统体外方法(如抗体产生和病原体中和/调理吞噬)与免疫动物生存之间的技术空白。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination has significantly reduced the incidence of invasive infections caused by several bacterial pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. However, no vaccines are available for many other invasive pathogens. A major hurdle in vaccine development is the lack of functional markers to quantify vaccine immunity in eliminating pathogens during the process of infection. Based on our recent discovery of the liver as the major organ of vaccine-induced clearance of blood-borne virulent bacteria, we here describe a new vaccine evaluation system that quantitatively characterizes the key features of effective vaccines in shuffling virulent bacteria from the blood circulation to the liver resident macrophage Kupffer cells (KCs) and sinusoidal endothelial cells (LSECs) in mouse septic infection model. This system consists of three related correlates or assays: pathogen clearance from the bloodstream, pathogen trapping in the liver, and pathogen capture by KCs/LSECs. These readouts were consistently associated with the serotype-specific immunoprotection levels of the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) against lethal infection of S. pneumoniae, a major invasive Gram-positive pathogen of community-acquired infections in humans. Furthermore, the reliability and sensitivity of these correlates in reflecting vaccine efficacy were verified with whole cell vaccines of Klebsiella pneumoniae and Escherichia coli, two major Gram-negative pathogens in hospital-acquired invasive infections. This system may be used as effective readouts to evaluate the immunoprotective potential of vaccine candidates in the preclinical phase by filling the current technical gap in vaccine evaluation between the conventional in vitro approaches (e.g. antibody production and pathogen neutralization/opsonophagocytosis) and survival of immunized animals.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tian X, Wang J, Chen H, et al. In vivo functional immunoprotection correlates for vaccines against invasive bacteria. Vaccine. 2024. PMID: 38233287. doi:10.1016/j.vaccine.2024.01.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。